Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 1,916 | 55,846 | 71,095 | 37,471 |
| Gross Profit | 1,916 | 55,846 | 71,095 | 37,471 |
| Operating Expenses | 59,353 | 37,332 | 14,077 | 17,522 |
| Operating Income | -57,437 | 18,514 | 57,018 | 19,949 |
| Other Income | 363 | -917 | -4,906 | -1,913 |
| Pre-tax Income | -57,074 | 17,597 | 52,112 | 18,036 |
| Income Tax | -5,272 | 7,374 | 1,191 | 300 |
| Net Income Continuous | -51,802 | 10,223 | 50,921 | 17,736 |
| Net Income | $-51,802 | $10,223 | $50,921 | $17,736 |
| EPS Basic Total Ops | -2.86 | 0.60 | 3.48 | 1.21 |
| EPS Basic Continuous Ops | -2.86 | 0.69 | 5.36 | 1.87 |
| EPS Diluted Total Ops | -2.86 | 0.53 | 2.99 | 1.17 |
| EPS Diluted Continuous Ops | -2.86 | 0.60 | 4.31 | 1.79 |
| EPS Diluted Before Non-Recurring Items | -2.86 | N/A | N/A | N/A |
| EBITDA(a) | $-56,127 | $17,308 | $57,084 | $19,990 |